INS and obesity disorder: Interestingly, despite the well described pro-inflammatory effects of systemic IL-6 in obesity and metabolic diseases, clinical studies show that IL-6 secreted by contracting skeletal muscle exerts anti-inflammatory effects and promotes favourable metabolic responses, also increasing insulin sensitivity [50].